New Delhi:The National Pharmaceutical Pricing Authority (NPPA), under the Department of Pharmaceuticals, Ministry of Chemicals and Fertilizers, has extended the applicability of ceiling prices for orthopaedic knee implants used in knee replacement systems for a further two months, i.e., up to 15th November 2025. The Authority had originally notified the ceiling prices of orthopaedic knee implants vide S.O. 2668(E), dated 16th August 2017, under which maximum retail prices were fixed for various categories of knee replacement systems. These prices were periodically revised and extended, with the last extension issued via notification S.O. 3869(E), dated 10th September 2024, which was valid till 15th September 2025. According to the latest notification S.O. 4171(E), dated 15th September 2025, NPPA stated: The Authority also clarified that the Notes (b) to (t) of the original 2017 order (S.O. 2668(E)) shall continue to remain in force during this extension period. The decision comes while representations from manufacturers and industry associations regarding revision of ceiling prices are still under consideration by NPPA. NPPA had capped the prices of knee implants in 2017 to curb exorbitant costs, bringing down overall procedure expenses for patients by up to 70%. The move was hailed as a landmark step in medical device price regulation. The Authority has since been reviewing industry feedback and extending the notified prices from time to time to maintain regulatory stability. To view the official notice click the link below: